69 related articles for article (PubMed ID: 23975316)
1. Prognostic significance of the immuno-peritoneal cancer index in peritoneal metastatic patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Yildirim Y; Sokmen S; Cevlik AD; Bisgin T; Manoglu B; Obuz F
Langenbecks Arch Surg; 2023 May; 408(1):182. PubMed ID: 37148400
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy.
Yonemura Y; Canbay E; Ishibashi H
ScientificWorldJournal; 2013; 2013():978394. PubMed ID: 23710154
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of preoperative chemotherapy for colorectal cancer with peritoneal metastasis underwent cytoreductive surgery.
Peng B; Liu Z; Huang B; Zhang Y; Su Y; Wang H; Wang Y; Luo R
Clin Transl Oncol; 2024 Jan; 26(1):269-277. PubMed ID: 37355530
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer: prevention and management of metastatic disease.
Sugarbaker PH
Biomed Res Int; 2014; 2014():782890. PubMed ID: 24783222
[TBL] [Abstract][Full Text] [Related]
5. Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC.
Simkens GA; Wintjens AGWE; Rovers KP; Nienhuijs SW; de Hingh IH
Cancer Manag Res; 2021; 13():5239-5249. PubMed ID: 34234566
[TBL] [Abstract][Full Text] [Related]
6. Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer.
Yang SY; Kang JH; Kim HS; Han YD; Min BS; Lee KY
J Gastrointest Oncol; 2019 Dec; 10(6):1251-1265. PubMed ID: 31949946
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options.
Vassos N; Piso P
Curr Treat Options Oncol; 2018 Sep; 19(10):49. PubMed ID: 30173342
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Assessment of Cancer Patients with Peritoneal Metastases for Complete Cytoreduction.
Sugarbaker PH
Indian J Surg Oncol; 2016 Sep; 7(3):295-302. PubMed ID: 27651688
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options for peritoneal metastasis arising from colorectal cancer.
Glockzin G; Schlitt HJ; Piso P
World J Gastrointest Pharmacol Ther; 2016 Aug; 7(3):343-52. PubMed ID: 27602235
[TBL] [Abstract][Full Text] [Related]
10. Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives.
Spiliotis J; Halkia E; de Bree E
Curr Oncol; 2016 Jun; 23(3):e266-75. PubMed ID: 27330364
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Relevance of the Peritoneal Surface Disease Severity Score Compared to the Peritoneal Cancer Index for Colorectal Peritoneal Carcinomatosis.
Ng JL; Ong WS; Chia CS; Tan GH; Soo KC; Teo MC
Int J Surg Oncol; 2016; 2016():2495131. PubMed ID: 27006828
[TBL] [Abstract][Full Text] [Related]
12. Multimodality treatment strategies have changed prognosis of peritoneal metastases.
Lungoci C; Mironiuc AI; Muntean V; Oniu T; Leebmann H; Mayr M; Piso P
World J Gastrointest Oncol; 2016 Jan; 8(1):67-82. PubMed ID: 26798438
[TBL] [Abstract][Full Text] [Related]
13. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Braam HJ; van Oudheusden TR; de Hingh IH; Nienhuijs SW; Boerma D; Wiezer MJ; van Ramshorst B
J Surg Oncol; 2014 Jun; 109(8):841-7. PubMed ID: 24619813
[TBL] [Abstract][Full Text] [Related]
14. Prognostic scores for colorectal cancer with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Enblad M; Ghanipour L; Cashin PH
Int J Hyperthermia; 2018 Dec; 34(8):1390-1395. PubMed ID: 29695209
[TBL] [Abstract][Full Text] [Related]
15. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
[TBL] [Abstract][Full Text] [Related]
16. A critical look at local-regional management of peritoneal metastasis.
Chan CH; Cusack JC; Ryan DP
Hematol Oncol Clin North Am; 2015 Feb; 29(1):153-8. PubMed ID: 25475577
[TBL] [Abstract][Full Text] [Related]
17. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
[TBL] [Abstract][Full Text] [Related]
18. Comparison of prognostic scores for patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Cashin PH; Graf W; Nygren P; Mahteme H
Ann Surg Oncol; 2013 Dec; 20(13):4183-9. PubMed ID: 23975316
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
